Table 3 The histological diagnosis of AIP by EUS-FNB and EUS-FNA
References | Study design | Needle | Number of patients | Successful tissue acquisition for histological evaluation | Type 1 AIP | Type 2 AIP | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Level 1 | Level 2 | Lympho-plasmacytic infiltration | IgG4-positive cells ≥ 10/HPF | Storiform fibrosis | Obliterative phlebitis | Level 1 | Level 2 | |||||
Levy [11] | Retrospective | 19G Quick Core | 3 | 100% | NM | NM | 66% | NM | NM | NM | 0 | 0 |
Mizuno [12] | Retrospective | 19G Quick Core | 14 | 100% | 57% | 21% | 100% | 64% | 93% | 36% | 0 | 0 |
Imai [13] | Retrospective | 22G NA-11Â J-KB, 22G Echotip | 21 | 100% | NM | NM | 52% | 0 | 0 | 0 | 0 | 0 |
Iwashita [14] | Retrospective | 19G EchoTip | 44 | 93% | NM | NM | 52% | 11% | 86% | 48% | 0 | 0 |
Ishikawa [15] | Retrospective | 22G EZ shot | 47 | 91% | 19% | 11% | 34% | 35% (10/28b) | 72% | 0 | 0 | 6% |
Kanno [16] | Retrospective | 22G NA-11Â J-KB, 22G EchoTip | 25 | 80%a | 56% | 24% | 92% | 36% | 80% | 40%c | 4% | 0 |
Kanno [17] | Prospective | 22G Expect | 78 | 79%e | 41% | 17% | 55% | 24% | 63% | 49% | 0 | 0 |
Morishima [18] | Prospective | 22G Expect, 22G Expect slim, 22G EchoTip, 22G NA-11Â J-KB | 45 | NM | 0 | 60% | 80% | 60% | 0 | 0 | 6% | 2% |
Cao [19] | Prospective | 22G EchoTip ultra | 27 | 93%d | 19% | 44% | 67% | 30% | 67% | 0 | 0 | 0 |
Bhattacharya [20] | Retrospective | 22G SharkCore | 2 | 100% | 100% | 0 | 100% | 100% | 100% | 0 | 0 | 0 |
Kurita [21] | Prospective | 22G Acquire | 50 | 88% | 56% | 22% | 84% | 76% | 56% | 24% | 0 | 0 |
20G Procore | 51 | 76% | 26% | 20% | 60% | 43% | 25% | 14% | Â | Â | ||
This article | Retrospective | 21G Sonopsy | 14 | 100% | 36% | 29% | 86% | 64% | 36% | 7% | 0 | 0 |